<DOC>
	<DOCNO>NCT00671242</DOCNO>
	<brief_summary>Purpose : L- [ 3-18F ] -α-methyltyrosine ( 18F-FMT ) amino-acid tracer PET . We conduct clinicopathologic study elucidate correlation angiogenesis 18F-FMT 18F-FDG uptake patient non-small cell lung cancer ( NSCLC ) . Method : Thirty-seven NSCLC patient enrol study , pair PET study 18F-FMT 18F-FDG performed . Uptake PET tracer evaluate standardized uptake value . VEGF , CD31 , CD34 , LAT1 Ki-67 label index resect tumor analyze immunohistochemical staining , correlate clinicopathologic variable uptake PET tracer .</brief_summary>
	<brief_title>Angiogenesis With Positron Emission Tomography ( PET ) Tracer Uptake</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patients underwent thoracotomy within 4 week 18FFMT PET 18FFDG PET study Histology nonsmall cell lung cancer Patient receive neoadjuvant chemotherapy radiotherapy surgery Patients insulindependent diabetes</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Fluorine-18-α-methyltyrosine ,</keyword>
	<keyword>Positron emission tomography ,</keyword>
	<keyword>Fluorine-18-fluorodeoxyglucose ,</keyword>
	<keyword>Lung cancer ,</keyword>
	<keyword>Angiogenesis</keyword>
	<keyword>The median VEGF rate 45 % ( range , 10-78 % ) .</keyword>
	<keyword>High expression see 30 patient ( 81 % , 30/37 ) .</keyword>
	<keyword>VEGF expression statistically associate progressively grow microvessel count .</keyword>
</DOC>